Expression of EVEC in ovarian carcinoma and its biological significance.
- Author:
Qian WANG
1
;
Xin-guo LI
;
Yi ZHANG
;
Lan-qin CAO
;
Zheng-hao DENG
;
Yong CHEN
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Carcinoma, Endometrioid; genetics; metabolism; pathology; secondary; Cystadenocarcinoma, Mucinous; genetics; metabolism; pathology; secondary; Cystadenocarcinoma, Serous; genetics; metabolism; pathology; secondary; Extracellular Matrix Proteins; genetics; metabolism; Female; Humans; Middle Aged; Neoplasm Staging; Omentum; metabolism; Ovarian Neoplasms; genetics; metabolism; pathology; Ovary; metabolism; Peritoneal Neoplasms; genetics; metabolism; secondary; RNA, Messenger; metabolism
- From: Chinese Journal of Oncology 2010;32(9):676-680
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the expression of EVEC in ovarian carcinoma and explore its biological significance.
METHODSThe expression of EVEC in 22 specimens of normal ovarian tissues and 63 specimens of ovarian cancers was detected by RT-PCR and Western blotting analysis, respectively.
RESULTSRT-PCR showed that the expression level of EVEC in stage I-II ovarian cancer (0.199 ± 0.014) was significantly higher than that in stage III-IV ovarian cancer (0.155 ± 0.015, P < 0.05), and significantly lower than that in normal ovarian tissues (0.415 ± 0.055, P < 0.05). There was no significant difference between the expression levels of EVEC in primary sites and that in corresponding metastatic sites of ovarian cancer (P > 0.05). Furthermore, the results of Western blot also showed that the protein expression level of EVEC in stage I-II ovarian cancer was also significantly lower than that in normal ovarian tissues (0.179 ± 0.026 vs. 0.543 ± 0.032, P < 0.05), and higher than that in stage III-IV ovarian cancer (0.179 ± 0.026 vs. 0.115 ± 0.023, P < 0.05). The EVEC expression level in the epiploic metastasis of stage I-II ovarian cancer was significantly higher than that of stage III-IV ovarian cancer (0.201 ± 0.028 vs. 0.101 ± 0.037, P < 0.05). The expression of EVEC in ovarian carcinoma had no correlation with age, pathologic classification and histological grade (P > 0.05).
CONCLUSIONSEVEC is closely related with carcinoma metastasis. The expression of EVEC in ovarian cancer and its metastatic sites was remarkably decreased. EVEC may play a negative role in the development and metastasis of ovarian cancer and may be a valuable marker in estimation of the prognosis for patients.
